One‐year clinical outcomes and multislice computed tomography angiographic results following implantation of the NeoVas bioresorbable sirolimus‐eluting scaffold in patients with single de novo coronary artery lesions

One‐year clinical outcomes and multislice computed tomography angiographic results following... INTRODUCTIONBioresorbable scaffolds have been heralded as the latest revolution in the field of percutaneous coronary intervention (PCI) . Unlike permanent metallic drug‐eluting stents (DES), bioresorbable scaffolds are designed to provide temporary structural integrity before being resorbed completely within the vessel. The transient presence of the scaffold offers a potential solution to the drawbacks of metallic DES; these drawbacks include hypersensitivity reactions, endothelial dysfunction, late stent thrombosis (ST), and preclusion of future surgical revascularization at the same lesion . With rapid technological advancement, cardiac multislice computed tomography (MSCT) angiography is currently considered to be an established technique for noninvasive evaluation of the coronary lumen and coronary plaques . However, MSCT assessment of a previously stented coronary artery is limited because of metal artifacts. Because of its radiolucent, polylactide backbone, the NeoVas scaffold does not affect computed tomography image interpretation, and MSCT can be used to assess changes in the lumen and vessels after its implantation.The angiographic, intravascular ultrasonography (IVUS), and optical coherence tomography (OCT) outcomes of this study were previously reported at the 6 months follow‐up . However, the clinical outcomes of the NeoVas scaffold for patients with single de novo lesions and plaque and lumen evolution at the 1 year follow‐up http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Catheterization and Cardiovascular Interventions Wiley

One‐year clinical outcomes and multislice computed tomography angiographic results following implantation of the NeoVas bioresorbable sirolimus‐eluting scaffold in patients with single de novo coronary artery lesions

Loading next page...
 
/lp/wiley/one-year-clinical-outcomes-and-multislice-computed-tomography-FG0pnCjTQ1
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 Wiley Periodicals, Inc.
ISSN
1522-1946
eISSN
1522-726X
D.O.I.
10.1002/ccd.27491
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONBioresorbable scaffolds have been heralded as the latest revolution in the field of percutaneous coronary intervention (PCI) . Unlike permanent metallic drug‐eluting stents (DES), bioresorbable scaffolds are designed to provide temporary structural integrity before being resorbed completely within the vessel. The transient presence of the scaffold offers a potential solution to the drawbacks of metallic DES; these drawbacks include hypersensitivity reactions, endothelial dysfunction, late stent thrombosis (ST), and preclusion of future surgical revascularization at the same lesion . With rapid technological advancement, cardiac multislice computed tomography (MSCT) angiography is currently considered to be an established technique for noninvasive evaluation of the coronary lumen and coronary plaques . However, MSCT assessment of a previously stented coronary artery is limited because of metal artifacts. Because of its radiolucent, polylactide backbone, the NeoVas scaffold does not affect computed tomography image interpretation, and MSCT can be used to assess changes in the lumen and vessels after its implantation.The angiographic, intravascular ultrasonography (IVUS), and optical coherence tomography (OCT) outcomes of this study were previously reported at the 6 months follow‐up . However, the clinical outcomes of the NeoVas scaffold for patients with single de novo lesions and plaque and lumen evolution at the 1 year follow‐up

Journal

Catheterization and Cardiovascular InterventionsWiley

Published: Jan 15, 2018

Keywords: ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off